The US Food and Drug Administration on Saturday authorized Johnson & Johnson’s single-dose COVID-19 vaccine for emergency use, making it the third vaccine on the US market. The OK comes a day after the FDA Vaccines and Related Biological Products Advisory Committee unanimously voted to approve the vaccine.
“The FDA, through our open and transparent scientific review process, has now authorized three COVID-19 vaccines with the urgency called for during this pandemic, using the agency’s rigorous standards for safety, effectiveness and manufacturing quality needed to…